Autophagy and mitophagy in diabetic cardiomyopathy

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1852, Issue 2, 2015, Pages 252-261

  Kobayashi, Satoru ^a   Liang, Qiangrong ^a  

^a NEW YORK INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Autophagy; Diabetes; Diabetic cardiomyopathy; Mitochondrion; Mitophagy

Indexed keywords

REACTIVE OXYGEN METABOLITE;

APOPTOSIS; AUTOLYSOSOME; AUTOPHAGOSOME; AUTOPHAGY; CAUSE OF DEATH; CELL DEATH; DIABETIC CARDIOMYOPATHY; DIABETIC PATIENT; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENERGY METABOLISM; ENERGY YIELD; HEART FAILURE; HEART FUNCTION; HEART INJURY; HOMEOSTASIS; HUMAN; INNER MEMBRANE; MITOPHAGY; NONHUMAN; OUTER MEMBRANE; PATHOGENESIS; PROTEIN QUALITY; QUALITY CONTROL; REGULATORY MECHANISM; REVIEW; STARVATION; ANIMAL; METABOLISM; MITOCHONDRION; PATHOLOGY;

ANIMALIA;

ANIMALS; AUTOPHAGY; DIABETIC CARDIOMYOPATHIES; HOMEOSTASIS; HUMANS; MITOCHONDRIA; MITOCHONDRIAL DEGRADATION; REACTIVE OXYGEN SPECIES;

EID: 84919822611     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2014.05.020     Document Type: Review

References (150)

1. Shaid S., Brandts C.H., Serve H., Dikic I. Ubiquitination and selective autophagy. Cell Death Differ. 2013, 20:21-30.
2. Ding W.X., Ni H.M., Li M., Liao Y., Chen X., Stolz D.B., Dorn G.W., Yin X.M. Nix is critical to two distinct phases of mitophagy, reactive oxygen species-mediated autophagy induction and Parkin-ubiquitin-p62-mediated mitochondrial priming. J. Biol. Chem. 2010, 285:27879-27890.
3. Zhang J., Ney P.A. Role of BNIP3 and NIX in cell death, autophagy, and mitophagy. Cell Death Differ. 2009, 16:939-946.
4. Liu L., Feng D., Chen G., Chen M., Zheng Q., Song P., Ma Q., Zhu C., Wang R., Qi W., et al. Mitochondrial outer-membrane protein FUNDC1 mediates hypoxia-induced mitophagy in mammalian cells. Nat. Cell Biol. 2012, 14:177-185.
5. Gomes L.C., Di Benedetto G., Scorrano L. During autophagy mitochondria elongate, are spared from degradation and sustain cell viability. Nat. Cell Biol. 2011, 13:589-598.
6. Bell D.S. Diabetic cardiomyopathy. A unique entity or a complication of coronary artery disease?. Diabetes Care 1995, 18:708-714.
7. Boudina S., Abel E.D. Diabetic cardiomyopathy revisited. Circulation 2007, 115:3213-3223.
8. Poornima I.G., Parikh P., Shannon R.P. Diabetic cardiomyopathy: the search for a unifying hypothesis. Circ. Res. 2006, 98:596-605.
9. Wold L.E., Ceylan-Isik A.F., Ren J. Oxidative stress and stress signaling: menace of diabetic cardiomyopathy. Acta Pharmacol. Sin. 2005, 26:908-917.
10. Johansen J.S., Harris A.K., Rychly D.J., Ergul A. Oxidative stress and the use of antioxidants in diabetes: linking basic science to clinical practice. Cardiovasc. Diabetol. 2005, 4:5.
11. Yusuf S., Dagenais G., Pogue J., Bosch J., Sleight P. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N. Engl. J. Med. 2000, 342:154-160.
12. Lonn E., Yusuf S., Hoogwerf B., Pogue J., Yi Q., Zinman B., Bosch J., Dagenais G., Mann J.F., Gerstein H.C. Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy. Diabetes Care 2002, 25:1919-1927.
13. Sacco M., Pellegrini F., Roncaglioni M.C., Avanzini F., Tognoni G., Nicolucci A. Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients: results of the Primary Prevention Project (PPP) trial. Diabetes Care 2003, 26:3264-3272.
14. Lonn E., Bosch J., Yusuf S., Sheridan P., Pogue J., Arnold J.M., Ross C., Arnold A., Sleight P., Probstfield J., et al. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA 2005, 293:1338-1347.
15. Shen X., Zheng S., Thongboonkerd V., Xu M., Pierce W.M., Klein J.B., Epstein P.N. Cardiac mitochondrial damage and biogenesis in a chronic model of type 1 diabetes. Am. J. Physiol. Endocrinol. Metab. 2004, 287:E896-E905.
16. Shen X., Ye G., Metreveli N.S., Epstein P.N. Cardiomyocyte defects in diabetic models and protection with cardiac-targeted transgenes. Methods Mol. Med. 2005, 112:379-388.
17. Nishikawa T., Edelstein D., Du X.L., Yamagishi S., Matsumura T., Kaneda Y., Yorek M.A., Beebe D., Oates P.J., Hammes H.P., et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000, 404:787-790.
18. Kristal B.S., Jackson C.T., Chung H.Y., Matsuda M., Nguyen H.D., Yu B.P. Defects at center P underlie diabetes-associated mitochondrial dysfunction. Free Radic. Biol. Med. 1997, 22:823-833.
19. Xie Z., Lau K., Eby B., Lozano P., He C., Pennington B., Li H., Rathi S., Dong Y., Tian R., et al. Improvement of cardiac functions by chronic metformin treatment is associated with enhanced cardiac autophagy in diabetic OVE26 mice. Diabetes 2011, 60:1770-1778.
20. Han Z., Cao J., Song D., Tian L., Chen K., Wang Y., Gao L., Yin Z., Fan Y., Wang C. Autophagy is involved in the cardioprotection effect of remote limb ischemic postconditioning on myocardial ischemia/reperfusion injury in normal mice, but not diabetic mice. PLoS ONE 2014, 9:e86838.
21. Zhao Y., Zhang L., Qiao Y., Zhou X., Wu G., Wang L., Peng Y., Dong X., Huang H., Si L., et al. Heme oxygenase-1 prevents cardiac dysfunction in streptozotocin-diabetic mice by reducing inflammation, oxidative stress, apoptosis and enhancing autophagy. PLoS ONE 2013, 8:e75927.
22. Xu X., Kobayashi S., Chen K., Timm D., Volden P., Huang Y., Gulick J., Yue Z., Robbins J., Epstein P.N., et al. Diminished autophagy limits cardiac injury in mouse models of type 1 diabetes. J. Biol. Chem. 2013, 288:18077-18092.
23. He C., Bassik M.C., Moresi V., Sun K., Wei Y., Zou Z., An Z., Loh J., Fisher J., Sun Q., et al. Exercise-induced BCL2-regulated autophagy is required for muscle glucose homeostasis. Nature 2012, 481:511-515.
24. Sciarretta S., Zhai P., Shao D., Maejima Y., Robbins J., Volpe M., Condorelli G., Sadoshima J. Rheb is a critical regulator of autophagy during myocardial ischemia: pathophysiological implications in obesity and metabolic syndrome. Circulation 2012, 125:1134-1146.
25. Guo R., Zhang Y., Turdi S., Ren J. Adiponectin knockout accentuates high fat diet-induced obesity and cardiac dysfunction: role of autophagy. Biochim. Biophys. Acta 2013, 1832:1136-1148.
26. Xu X., Hua Y., Nair S., Zhang Y., Ren J. Akt2 knockout preserves cardiac function in high-fat diet-induced obesity by rescuing cardiac autophagosome maturation. J. Mol. Cell Biol. 2013, 5:61-63.
27. Feng Y., He D., Yao Z., Klionsky D.J. The machinery of macroautophagy. Cell Res. 2014, 24:24-41.
28. Youle R.J., Narendra D.P. Mechanisms of mitophagy. Nat. Rev. Mol. Cell Biol. 2011, 12:9-14.
29. Kubli D.A., Gustafsson A.B. Mitochondria and mitophagy: the yin and yang of cell death control. Circ. Res. 2012, 111:1208-1221.
30. Ashrafi G., Schwarz T.L. The pathways of mitophagy for quality control and clearance of mitochondria. Cell Death Differ. 2013, 20:31-42.
31. Mizushima N., Komatsu M. Autophagy: renovation of cells and tissues. Cell 2011, 147:728-741.
32. Gottlieb R.A., Carreira R.S. Autophagy in health and disease. 5. Mitophagy as a way of life. Am. J. Physiol. Cell Physiol. 2010, 299:C203-C210.
33. Kabeya Y., Mizushima N., Yamamoto A., Oshitani-Okamoto S., Ohsumi Y., Yoshimori T. LC3, GABARAP and GATE16 localize to autophagosomal membrane depending on form-II formation. J. Cell Sci. 2004, 117:2805-2812.
34. Kim J., Kundu M., Viollet B., Guan K.L. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat. Cell Biol. 2011, 13:132-141.
35. Inoki K., Zhu T., Guan K.L. TSC2 mediates cellular energy response to control cell growth and survival. Cell 2003, 115:577-590.
36. Gwinn D.M., Shackelford D.B., Egan D.F., Mihaylova M.M., Mery A., Vasquez D.S., Turk B.E., Shaw R.J. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol. Cell 2008, 30:214-226.
37. Sanchez A.M., Csibi A., Raibon A., Cornille K., Gay S., Bernardi H., Candau R. AMPK promotes skeletal muscle autophagy through activation of forkhead FoxO3a and interaction with Ulk1. J. Cell. Biochem. 2012, 113:695-710.
38. Mammucari C., Milan G., Romanello V., Masiero E., Rudolf R., Del Piccolo P., Burden S.J., Di Lisi R., Sandri C., Zhao J., et al. FoxO3 controls autophagy in skeletal muscle in vivo. Cell Metab. 2007, 6:458-471.
39. Sengupta A., Molkentin J.D., Yutzey K.E. FoxO transcription factors promote autophagy in cardiomyocytes. J. Biol. Chem. 2009, 284:28319-28331.
40. He C., Zhu H., Li H., Zou M.H., Xie Z. Dissociation of Bcl-2-Beclin1 complex by activated AMPK enhances cardiac autophagy and protects against cardiomyocyte apoptosis in diabetes. Diabetes 2013, 62:1270-1281.
41. Kim J., Kim Y.C., Fang C., Russell R.C., Kim J.H., Fan W., Liu R., Zhong Q., Guan K.L. Differential regulation of distinct Vps34 complexes by AMPK in nutrient stress and autophagy. Cell 2013, 152:290-303.
42. Terman A., Brunk U.T. Autophagy in cardiac myocyte homeostasis, aging, and pathology. Cardiovasc. Res. 2005, 68:355-365.
43. Martinet W., Knaapen M.W., Kockx M.M., De Meyer G.R. Autophagy in cardiovascular disease. Trends Mol. Med. 2007, 13:482-491.
44. Takagi H., Matsui Y., Sadoshima J. The role of autophagy in mediating cell survival and death during ischemia and reperfusion in the heart. Antioxid. Redox Signal. 2007, 9:1373-1381.
45. Hamacher-Brady A., Brady N.R., Gottlieb R.A. The interplay between pro-death and pro-survival signaling pathways in myocardial ischemia/reperfusion injury: apoptosis meets autophagy. Cardiovasc. Drugs Ther. 2006, 20:445-462.
46. Taneike M., Yamaguchi O., Nakai A., Hikoso S., Takeda T., Mizote I., Oka T., Tamai T., Oyabu J., Murakawa T., et al. Inhibition of autophagy in the heart induces age-related cardiomyopathy. Autophagy 2010, 6:600-606.
47. Nakai A., Yamaguchi O., Takeda T., Higuchi Y., Hikoso S., Taniike M., Omiya S., Mizote I., Matsumura Y., Asahi M., et al. The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress. Nat. Med. 2007, 13:619-624.
48. Jaber N., Dou Z., Chen J.S., Catanzaro J., Jiang Y.P., Ballou L.M., Selinger E., Ouyang X., Lin R.Z., Zhang J., et al. Class III PI3K Vps34 plays an essential role in autophagy and in heart and liver function. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:2003-2008.
49. Cuervo A.M., Bergamini E., Brunk U.T., Droge W., Ffrench M., Terman A. Autophagy and aging: the importance of maintaining "clean" cells. Autophagy 2005, 1:131-140.
50. Matsui Y., Takagi H., Qu X., Abdellatif M., Sakoda H., Asano T., Levine B., Sadoshima J. Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy. Circ. Res. 2007, 100:914-922.
51. Kuma A., Hatano M., Matsui M., Yamamoto A., Nakaya H., Yoshimori T., Ohsumi Y., Tokuhisa T., Mizushima N. The role of autophagy during the early neonatal starvation period. Nature 2004, 432:1032-1036.
52. Yan L., Vatner D.E., Kim S.J., Ge H., Masurekar M., Massover W.H., Yang G., Matsui Y., Sadoshima J., Vatner S.F. Autophagy in chronically ischemic myocardium. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:13807-13812.
53. Huang C., Yitzhaki S., Perry C.N., Liu W., Giricz Z., Mentzer R.M., Gottlieb R.A. Autophagy induced by ischemic preconditioning is essential for cardioprotection. J. Cardiovasc. Transl. Res. 2010, 3:365-373.
54. Tannous P., Zhu H., Johnstone J.L., Shelton J.M., Rajasekaran N.S., Benjamin I.J., Nguyen L., Gerard R.D., Levine B., Rothermel B.A., et al. Autophagy is an adaptive response in desmin-related cardiomyopathy. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:9745-9750.
55. Akazawa H., Komazaki S., Shimomura H., Terasaki F., Zou Y., Takano H., Nagai T., Komuro I. Diphtheria toxin-induced autophagic cardiomyocyte death plays a pathogenic role in mouse model of heart failure. J. Biol. Chem. 2004, 279:41095-41103.
56. Lu L., Wu W., Yan J., Li X., Yu H., Yu X. Adriamycin-induced autophagic cardiomyocyte death plays a pathogenic role in a rat model of heart failure. Int. J. Cardiol. 2009, 134:82-90.
57. Zhu H., Tannous P., Johnstone J.L., Kong Y., Shelton J.M., Richardson J.A., Le V., Levine B., Rothermel B.A., Hill J.A. Cardiac autophagy is a maladaptive response to hemodynamic stress. J. Clin. Invest. 2007, 117:1782-1793.
58. Zhang D., Contu R., Latronico M.V., Zhang J., Rizzi R., Catalucci D., Miyamoto S., Huang K., Ceci M., Gu Y., et al. MTORC1 regulates cardiac function and myocyte survival through 4E-BP1 inhibition in mice. J. Clin. Invest. 2010, 120:2805-2816.
59. Shende P., Plaisance I., Morandi C., Pellieux C., Berthonneche C., Zorzato F., Krishnan J., Lerch R., Hall M.N., Ruegg M.A., et al. Cardiac raptor ablation impairs adaptive hypertrophy, alters metabolic gene expression, and causes heart failure in mice. Circulation 2011, 123:1073-1082.
60. Riehle C., Wende A.R., Sena S., Pires K.M., Pereira R.O., Zhu Y., Bugger H., Frank D., Bevins J., Chen D., et al. Insulin receptor substrate signaling suppresses neonatal autophagy in the heart. J. Clin. Invest. 2013, 123:5319-5333.
61. Kang C., Avery L. To be or not to be, the level of autophagy is the question: dual roles of autophagy in the survival response to starvation. Autophagy 2007, 4.
62. Karbowski M., Kurono C., Wozniak M., Ostrowski M., Teranishi M., Nishizawa Y., Usukura J., Soji T., Wakabayashi T. Free radical-induced megamitochondria formation and apoptosis. Free Radic. Biol. Med. 1999, 26:396-409.
63. Sachs H.G., Colgan J.A., Lazarus M.L. Ultrastructure of the aging myocardium: a morphometric approach. Am. J. Anat. 1977, 150:63-71.
64. Chen K., Kobayashi S., Xu X., Viollet B., Liang Q. AMP activated protein kinase is indispensable for myocardial adaptation to caloric restriction in mice. PLoS ONE 2013, 8:e59682.
65. Finckenberg P., Eriksson O., Baumann M., Merasto S., Lalowski M.M., Levijoki J., Haasio K., Kyto V., Muller D.N., Luft F.C., et al. Caloric restriction ameliorates angiotensin II-induced mitochondrial remodeling and cardiac hypertrophy. Hypertension 2012, 59:76-84.
66. Sohal R.S., Ku H.H., Agarwal S., Forster M.J., Lal H. Oxidative damage, mitochondrial oxidant generation and antioxidant defenses during aging and in response to food restriction in the mouse. Mech. Ageing Dev. 1994, 74:121-133.
67. Wohlgemuth S.E., Julian D., Akin D.E., Fried J., Toscano K., Leeuwenburgh C., Dunn W.A. Autophagy in the heart and liver during normal aging and calorie restriction. Rejuvenation Res. 2007, 10:281-292.
68. Pallet N., Bouvier N., Legendre C., Gilleron J., Codogno P., Beaune P., Thervet E., Anglicheau D. Autophagy protects renal tubular cells against cyclosporine toxicity. Autophagy 2008, 4:783-791.
69. Grumati P., Coletto L., Sabatelli P., Cescon M., Angelin A., Bertaggia E., Blaauw B., Urciuolo A., Tiepolo T., Merlini L., et al. Autophagy is defective in collagen VI muscular dystrophies, and its reactivation rescues myofiber degeneration. Nat. Med. 2010, 16:1313-1320.
70. Cotan D., Cordero M.D., Garrido-Maraver J., Oropesa-Avila M., Rodriguez-Hernandez A., Gomez Izquierdo L., De la Mata M., De Miguel M., Lorite J.B., Infante E.R., et al. Secondary coenzyme Q10 deficiency triggers mitochondria degradation by mitophagy in MELAS fibroblasts. FASEB J. 2011, 25:2669-2687.
71. Rodriguez-Hernandez A., Cordero M.D., Salviati L., Artuch R., Pineda M., Briones P., Gomez Izquierdo L., Cotan D., Navas P., Sanchez-Alcazar J.A. Coenzyme Q deficiency triggers mitochondria degradation by mitophagy. Autophagy 2009, 5:19-32.
72. Twig G., Elorza A., Molina A.J., Mohamed H., Wikstrom J.D., Walzer G., Stiles L., Haigh S.E., Katz S., Las G., et al. Fission and selective fusion govern mitochondrial segregation and elimination by autophagy. EMBO J. 2008, 27:433-446.
73. Narendra D.P., Jin S.M., Tanaka A., Suen D.F., Gautier C.A., Shen J., Cookson M.R., Youle R.J. PINK1 is selectively stabilized on impaired mitochondria to activate Parkin. PLoS Biol. 2010, 8:e1000298.
74. Chen Y., Dorn G.W. PINK1-phosphorylated mitofusin 2 is a Parkin receptor for culling damaged mitochondria. Science 2013, 340:471-475.
75. Iguchi M., Kujuro Y., Okatsu K., Koyano F., Kosako H., Kimura M., Suzuki N., Uchiyama S., Tanaka K., Matsuda N. Parkin-catalyzed ubiquitin-ester transfer is triggered by PINK1-dependent phosphorylation. J. Biol. Chem. 2013, 288:22019-22032.
76. Kazlauskaite A., Kondapalli C., Gourlay R., Campbell D.G., Ritorto M.S., Hofmann K., Alessi D.R., Knebel A., Trost M., Muqit M.M. Parkin is activated by PINK1-dependent phosphorylation of ubiquitin at Ser65. Biochem. J. 2014, 460:127-139.
77. Geisler S., Holmstrom K.M., Treis A., Skujat D., Weber S.S., Fiesel F.C., Kahle P.J., Springer W. The PINK1/Parkin-mediated mitophagy is compromised by PD-associated mutations. Autophagy 2010, 6:871-878.
78. Matsuda N., Sato S., Shiba K., Okatsu K., Saisho K., Gautier C.A., Sou Y.S., Saiki S., Kawajiri S., Sato F., et al. PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy. J. Cell Biol. 2010, 189:211-221.
79. A. Tanaka, Parkin-mediated selective mitochondrial autophagy, mitophagy: Parkin purges damaged organelles from the vital mitochondrial network. FEBS Lett. 584 1386-1392.
80. Vives-Bauza C., Zhou C., Huang Y., Cui M., de Vries R.L., Kim J., May J., Tocilescu M.A., Liu W., Ko H.S., et al. PINK1-dependent recruitment of Parkin to mitochondria in mitophagy. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:378-383.
81. Narendra D., Tanaka A., Suen D.F., Youle R.J. Parkin-induced mitophagy in the pathogenesis of Parkinson disease. Autophagy 2009, 5:706-708.
82. Tanaka A. Parkin-mediated selective mitochondrial autophagy, mitophagy: Parkin purges damaged organelles from the vital mitochondrial network. FEBS Lett. 2010, 584:1386-1392.
83. Tanaka A., Cleland M.M., Xu S., Narendra D.P., Suen D.F., Karbowski M., Youle R.J. Proteasome and p97 mediate mitophagy and degradation of mitofusins induced by Parkin. J. Cell Biol. 2010, 191:1367-1380.
84. Gegg M.E., Cooper J.M., Chau K.Y., Rojo M., Schapira A.H., Taanman J.W. Mitofusin 1 and mitofusin 2 are ubiquitinated in a PINK1/parkin-dependent manner upon induction of mitophagy. Hum. Mol. Genet. 2010, 19:4861-4870.
85. Okatsu K., Saisho K., Shimanuki M., Nakada K., Shitara H., Sou Y.S., Kimura M., Sato S., Hattori N., Komatsu M., et al. p62/SQSTM1 cooperates with Parkin for perinuclear clustering of depolarized mitochondria. Genes Cells 2010, 15:887-900.
86. Lee J.Y., Nagano Y., Taylor J.P., Lim K.L., Yao T.P. Disease-causing mutations in parkin impair mitochondrial ubiquitination, aggregation, and HDAC6-dependent mitophagy. J. Cell Biol. 2010, 189:671-679.
87. Geisler S., Holmstrom K.M., Skujat D., Fiesel F.C., Rothfuss O.C., Kahle P.J., Springer W. PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nat. Cell Biol. 2010, 12:119-131.
88. Orvedahl A., Sumpter R., Xiao G., Ng A., Zou Z., Tang Y., Narimatsu M., Gilpin C., Sun Q., Roth M., et al. Image-based genome-wide siRNA screen identifies selective autophagy factors. Nature 2011, 480:113-117.
89. Novak I., Kirkin V., McEwan D.G., Zhang J., Wild P., Rozenknop A., Rogov V., Lohr F., Popovic D., Occhipinti A., et al. Nix is a selective autophagy receptor for mitochondrial clearance. EMBO Rep. 2010, 11:45-51.
90. Hanna R.A., Quinsay M.N., Orogo A.M., Giang K., Rikka S., Gustafsson A.B. Microtubule-associated protein 1 light chain 3 (LC3) interacts with Bnip3 protein to selectively remove endoplasmic reticulum and mitochondria via autophagy. J. Biol. Chem. 2012, 287:19094-19104.
91. Elmore S.P., Qian T., Grissom S.F., Lemasters J.J. The mitochondrial permeability transition initiates autophagy in rat hepatocytes. FASEB J. 2001, 15:2286-2287.
92. Wu W., Tian W., Hu Z., Chen G., Huang L., Li W., Zhang X., Xue P., Zhou C., Liu L., et al. ULK1 translocates to mitochondria and phosphorylates FUNDC1 to regulate mitophagy. EMBO Rep. 2014, 15:566-575.
93. Mijaljica D., Prescott M., Devenish R.J. A fluorescence microscopy assay for monitoring mitophagy in the yeast Saccharomyces cerevisiae. J. Vis. Exp. 2011, 53:2779.
94. Allen G.F., Toth R., James J., Ganley I.G. Loss of iron triggers PINK1/Parkin-independent mitophagy. EMBO Rep. 2013, 14:1127-1135.
95. Katayama H., Kogure T., Mizushima N., Yoshimori T., Miyawaki A. A sensitive and quantitative technique for detecting autophagic events based on lysosomal delivery. Chem. Biol. 2011, 18:1042-1052.
96. Huang C., Andres A.M., Ratliff E.P., Hernandez G., Lee P., Gottlieb R.A. Preconditioning involves selective mitophagy mediated by Parkin and p62/SQSTM1. PLoS ONE 2011, 6:e20975.
97. Kubli D.A., Zhang X., Lee Y., Hanna R.A., Quinsay M.N., Nguyen C.K., Jimenez R., Petrosyan S., Murphy A.N., Gustafsson A.B. Parkin protein deficiency exacerbates cardiac injury and reduces survival following myocardial infarction. J. Biol. Chem. 2013, 288:915-926.
98. Andres A.M., Hernandez G., Lee P., Huang C., Ratliff E.P., Sin J., Thornton C.A., Damasco M.V., Gottlieb R.A. Mitophagy is required for acute cardioprotection by simvastatin. Antioxid. Redox Signal. 2013, [in press, Epub ahead of print].
99. Piquereau J., Godin R., Deschenes S., Bessi V.L., Mofarrahi M., Hussain S.N., Burelle Y. Protective role of PARK2/Parkin in sepsis-induced cardiac contractile and mitochondrial dysfunction. Autophagy 2013, 9:1837-1851.
100. Hoshino A., Mita Y., Okawa Y., Ariyoshi M., Iwai-Kanai E., Ueyama T., Ikeda K., Ogata T., Matoba S. Cytosolic p53 inhibits Parkin-mediated mitophagy and promotes mitochondrial dysfunction in the mouse heart. Nat. Commun. 2013, 4:2308.
101. Kubli D.A., Quinsay M.N., Gustafsson A.B. Parkin deficiency results in accumulation of abnormal mitochondria in aging myocytes. Commun. Integr. Biol. 2013, 6:e24511.
102. Bhandari P., Song M., Chen Y., Burelle Y., Dorn G.W. Mitochondrial contagion induced by Parkin deficiency in Drosophila hearts and its containment by suppressing mitofusin. Circ. Res. 2014, 114:257-265.
103. Gottlieb R.A., Mentzer R.M., Linton P.J. Impaired mitophagy at the heart of injury. Autophagy 2011, 7:1573-1574.
104. Narendra D., Tanaka A., Suen D.F., Youle R.J. Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J. Cell Biol. 2008, 183:795-803.
105. Dorn G.W. Mitochondrial pruning by Nix and BNip3: an essential function for cardiac-expressed death factors. J. Cardiovasc. Transl. Res. 2010, 3:374-383.
106. Chen Y., Liu Y., Dorn G.W. Mitochondrial fusion is essential for organelle function and cardiac homeostasis. Circ. Res. 2011, 109:1327-1331.
107. Ong S.B., Subrayan S., Lim S.Y., Yellon D.M., Davidson S.M., Hausenloy D.J. Inhibiting mitochondrial fission protects the heart against ischemia/reperfusion injury. Circulation 2010, 121:2012-2022.
108. Nishida Y., Arakawa S., Fujitani K., Yamaguchi H., Mizuta T., Kanaseki T., Komatsu M., Otsu K., Tsujimoto Y., Shimizu S. Discovery of Atg5/Atg7-independent alternative macroautophagy. Nature 2009, 461:654-658.
109. Brady N.R., Hamacher-Brady A., Westerhoff H.V., Gottlieb R.A. A wave of reactive oxygen species (ROS)-induced ROS release in a sea of excitable mitochondria. Antioxid. Redox Signal. 2006, 8:1651-1665.
110. Zorov D.B., Juhaszova M., Sollott S.J. Mitochondrial ROS-induced ROS release: an update and review. Biochim. Biophys. Acta 2006, 1757:509-517.
111. Cai L., Li W., Wang G., Guo L., Jiang Y., Kang Y.J. Hyperglycemia-induced apoptosis in mouse myocardium: mitochondrial cytochrome C-mediated caspase-3 activation pathway. Diabetes 2002, 51:1938-1948.
112. Ghosh S., Pulinilkunnil T., Yuen G., Kewalramani G., An D., Qi D., Abrahani A., Rodrigues B. Cardiomyocyte apoptosis induced by short-term diabetes requires mitochondrial GSH depletion. Am. J. Physiol. Heart Circ. Physiol. 2005, 289:H768-H776.
113. Malhotra A., Begley R., Kang B.P., Rana I., Liu J., Yang G., Mochly-Rosen D., Meggs L.G. PKC-{varepsilon}-dependent survival signals in diabetic hearts. Am. J. Physiol. Heart Circ. Physiol. 2005, 289:H1343-H1350.
114. Shen X., Zheng S., Metreveli N.S., Epstein P.N. Protection of cardiac mitochondria by overexpression of MnSOD reduces diabetic cardiomyopathy. Diabetes 2006, 55:798-805.
115. Frustaci A., Kajstura J., Chimenti C., Jakoniuk I., Leri A., Maseri A., Nadal-Ginard B., Anversa P. Myocardial cell death in human diabetes. Circ. Res. 2000, 87:1123-1132.
116. Tomita M., Mukae S., Geshi E., Umetsu K., Nakatani M., Katagiri T. Mitochondrial respiratory impairment in streptozotocin-induced diabetic rat heart. Jpn. Circ. J. 1996, 60:673-682.
117. Boudina S., Abel E.D. Mitochondrial uncoupling: a key contributor to reduced cardiac efficiency in diabetes. Physiology (Bethesda) 2006, 21:250-258.
118. Bugger H., Abel E.D. Molecular mechanisms for myocardial mitochondrial dysfunction in the metabolic syndrome. Clin. Sci. (Lond.) 2008, 114:195-210.
119. Ye G., Metreveli N.S., Donthi R.V., Xia S., Xu M., Carlson E.C., Epstein P.N. Catalase protects cardiomyocyte function in models of type 1 and type 2 diabetes. Diabetes 2004, 53:1336-1343.
120. Liang Q., Carlson E.C., Donthi R.V., Kralik P.M., Shen X., Epstein P.N. Overexpression of metallothionein reduces diabetic cardiomyopathy. Diabetes 2002, 51:174-181.
121. Fiordaliso F., Bianchi R., Staszewsky L., Cuccovillo I., Doni M., Laragione T., Salio M., Savino C., Melucci S., Santangelo F., et al. Antioxidant treatment attenuates hyperglycemia-induced cardiomyocyte death in rats. J. Mol. Cell. Cardiol. 2004, 37:959-968.
122. Ye G., Metreveli N.S., Ren J., Epstein P.N. Metallothionein prevents diabetes-induced deficits in cardiomyocytes by inhibiting reactive oxygen species production. Diabetes 2003, 52:777-783.
123. Mizushima N. The pleiotropic role of autophagy: from protein metabolism to bactericide. Cell Death Differ. 2005, 12(Suppl. 2):1535-1541.
124. Meijer A.J., Codogno P. Signalling and autophagy regulation in health, aging and disease. Mol. Aspects Med. 2006, 27:411-425.
125. Meijer A.J., Codogno P. Macroautophagy: protector in the diabetes drama?. Autophagy 2007, 3:523-526.
126. Kobayashi S., Xu X., Chen K., Liang Q. Suppression of autophagy is protective in high glucose-induced cardiomyocyte injury. Autophagy 2012, 8:577-592.
127. Mei S., Ni H.M., Manley S., Bockus A., Kassel K.M., Luyendyk J.P., Copple B.L., Ding W.X. Differential roles of unsaturated and saturated fatty acids on autophagy and apoptosis in hepatocytes. J. Pharmacol. Exp. Ther. 2011, 339:487-498.
128. Cetrullo S., Tantini B., Flamigni F., Pazzini C., Facchini A., Stefanelli C., Caldarera C.M., Pignatti C. Antiapoptotic and antiautophagic effects of eicosapentaenoic acid in cardiac myoblasts exposed to palmitic acid. Nutrients 2012, 4:78-90.
129. Tanida I., Ueno T., Kominami E. LC3 conjugation system in mammalian autophagy. Int. J. Biochem. Cell Biol. 2004, 36:2503-2518.
130. Mellor K.M., Bell J.R., Young M.J., Ritchie R.H., Delbridge L.M. Myocardial autophagy activation and suppressed survival signaling is associated with insulin resistance in fructose-fed mice. J. Mol. Cell. Cardiol. 2011, 50:1035-1043.
131. Russo S.B., Baicu C.F., Van Laer A., Geng T., Kasiganesan H., Zile M.R., Cowart L.A. Ceramide synthase 5 mediates lipid-induced autophagy and hypertrophy in cardiomyocytes. J. Clin. Invest. 2012, 122:3919-3930.
132. French C.J., Tarikuz Zaman A., McElroy-Yaggy K.L., Neimane D.K., Sobel B.E. Absence of altered autophagy after myocardial ischemia in diabetic compared with nondiabetic mice. Coron. Artery Dis. 2011, 22:479-483.
133. Giricz Z., Mentzer R.M., Gottlieb R.A. Autophagy, myocardial protection, and the metabolic syndrome. J. Cardiovasc. Pharmacol. 2012, 60:125-132.
134. Perry C.N., Kyoi S., Hariharan N., Takagi H., Sadoshima J., Gottlieb R.A. Novel methods for measuring cardiac autophagy in vivo. Methods Enzymol. 2009, 453:325-342.
135. Iwai-Kanai E., Yuan H., Huang C., Sayen M.R., Perry-Garza C.N., Kim L., Gottlieb R.A. A method to measure cardiac autophagic flux in vivo. Autophagy 2008, 4:322-329.
136. Su H., Li F., Ranek M.J., Wei N., Wang X. COP9 signalosome regulates autophagosome maturation. Circulation 2011, 124:2117-2128.
137. Pankiv S., Clausen T.H., Lamark T., Brech A., Bruun J.A., Outzen H., Overvatn A., Bjorkoy G., Johansen T. p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J. Biol. Chem. 2007, 282:24131-24145.
138. Komatsu M., Waguri S., Koike M., Sou Y.S., Ueno T., Hara T., Mizushima N., Iwata J., Ezaki J., Murata S., et al. Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice. Cell 2007, 131:1149-1163.
139. Thomson D.M., Brown J.D., Fillmore N., Ellsworth S.K., Jacobs D.L., Winder W.W., Fick C.A., Gordon S.E. AMP-activated protein kinase response to contractions and treatment with the AMPK activator AICAR in young adult and old skeletal muscle. J. Physiol. 2009, 587:2077-2086.
140. Reznick R.M., Shulman G.I. The role of AMP-activated protein kinase in mitochondrial biogenesis. J. Physiol. 2006, 574:33-39.
141. Saeedi R., Parsons H.L., Wambolt R.B., Paulson K., Sharma V., Dyck J.R., Brownsey R.W., Allard M.F. Metabolic actions of metformin in the heart can occur by AMPK-independent mechanisms. Am. J. Physiol. Heart Circ. Physiol. 2008, 294:H2497-H2506.
142. Xu X., Lu Z., Fassett J., Zhang P., Hu X., Liu X., Kwak D., Li J., Zhu G., Tao Y., et al. Metformin protects against systolic overload-induced heart failure independent of AMP-activated protein kinase alpha2. Hypertension 2014, 63:723-728.
143. Das A., Durrant D., Koka S., Salloum F.N., Xi L., Kukreja R.C. Mammalian target of rapamycin (mTOR) inhibition with rapamycin improves cardiac function in type 2 diabetic mice: potential role of attenuated oxidative stress and altered contractile protein expression. J. Biol. Chem. 2014, 289:4145-4160.
144. Wei N., Yu S.P., Gu X.H., Chen D.D., Whalin M.K., Xu G.L., Liu X.F., Wei L. The involvement of autophagy pathway in exaggerated ischemic brain damage in diabetic mice. CNS Neurosci. Ther. 2013, 19:753-763.
145. Li S.Y., Fang C.X., Aberle N.S., Ren B.H., Ceylan-Isik A.F., Ren J. Inhibition of PI-3 kinase/Akt/mTOR, but not calcineurin signaling, reverses insulin-like growth factor I-induced protection against glucose toxicity in cardiomyocyte contractile function. J. Endocrinol. 2005, 186:491-503.
146. Kuzman J.A., O'Connell T.D., Gerdes A.M. Rapamycin prevents thyroid hormone-induced cardiac hypertrophy. Endocrinology 2007, 148:3477-3484.
147. Song X., Kusakari Y., Xiao C.Y., Kinsella S.D., Rosenberg M.A., Scherrer-Crosbie M., Hara K., Rosenzweig A., Matsui T. mTOR attenuates the inflammatory response in cardiomyocytes and prevents cardiac dysfunction in pathological hypertrophy. Am. J. Physiol. Cell Physiol. 2010, 299:C1256-C1266.
148. Hoshino A., Ariyoshi M., Okawa Y., Kaimoto S., Uchihashi M., Fukai K., Iwai-Kanai E., Ikeda K., Ueyama T., Ogata T., et al. Inhibition of p53 preserves Parkin-mediated mitophagy and pancreatic beta-cell function in diabetes. Proc. Natl. Acad. Sci. U. S. A. 2014, 111:3116-3121.
149. Scarlatti F., Maffei R., Beau I., Codogno P., Ghidoni R. Role of non-canonical Beclin 1-independent autophagy in cell death induced by resveratrol in human breast cancer cells. Cell Death Differ. 2008, 15:1318-1329.
150. Hailey D.W., Rambold A.S., Satpute-Krishnan P., Mitra K., Sougrat R., Kim P.K., Lippincott-Schwartz J. Mitochondria supply membranes for autophagosome biogenesis during starvation. Cell 2010, 141:656-667.